Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Lippman, SM"'
Autor:
Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California. smkato@ucsd.edu., Okamura R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Baumgartner JM; Division of Surgical Oncology, Department of Surgery, UC San Diego Moores Cancer Center, La Jolla, California., Patel H; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Leichman L; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Kelly K; Division of Surgical Oncology, Department of Surgery, UC San Diego Moores Cancer Center, La Jolla, California., Sicklick JK; Division of Surgical Oncology, Department of Surgery, UC San Diego Moores Cancer Center, La Jolla, California., Fanta PT; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Lippman SM; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California., Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Dec 15; Vol. 24 (24), pp. 6248-6256. Date of Electronic Publication: 2018 Oct 22.
Autor:
Goodman AM; Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla.; Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla.; Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego, La Jolla., Piccioni D; Division of Neurological Oncology, Department of Neurology, University of California, San Diego, La Jolla., Kato S; Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla.; Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla., Boichard A; Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla., Wang HY; Department of Pathology, University of California, San Diego, La Jolla., Frampton G; Foundation Medicine, Cambridge, Massachusetts., Lippman SM; Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla.; Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla., Connelly C; Foundation Medicine, Cambridge, Massachusetts., Fabrizio D; Foundation Medicine, Cambridge, Massachusetts., Miller V; Foundation Medicine, Cambridge, Massachusetts., Sicklick JK; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla., Kurzrock R; Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla.; Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla.
Publikováno v:
JAMA oncology [JAMA Oncol] 2018 Sep 01; Vol. 4 (9), pp. 1237-1244.
Autor:
Saintigny P; Cancer Research Center of Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France.; Department of Medicine, Centre Léon Bérard, Lyon, France.; Université Lyon 1, Lyon, France., William WN Jr; Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX., Foy JP; Cancer Research Center of Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France.; Université Lyon 1, Lyon, France., Papadimitrakopoulou V; Université Lyon 1, Lyon, France., Lang W; Université Lyon 1, Lyon, France., Zhang L; Bioinformatics and Computational Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX., Fan YH; Université Lyon 1, Lyon, France., Feng L; Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX., Kim ES; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC., El-Naggar AK; Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX., Lee JJ; Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX., Mao L; Oncology and Diagnostic Science, University of Maryland Dental School, Baltimore, MD., Hong WK; Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX., Lingen MW; Department of Pathology, The University of Chicago, Chicago, IL., Lippman SM; UC San Diego Moores Cancer Center, San Diego, CA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2018 Mar 01; Vol. 110 (3).
Autor:
Arun BK; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA. barun@mdanderson.org., Gong Y; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Liu D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Litton JK; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Gutierrez-Barrera AM; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Jack Lee J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vornik L; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ibrahim NK; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Cornelison T; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Hortobagyi GN; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Heckman-Stoddard BM; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Koenig KB; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Alvarez RR; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Murray JL; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Valero V; Breast Medical Oncology and Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, 1155 Pressler Street, CPB 5., Box 1354, Houston, TX, 77030, USA., Lippman SM; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Brown P; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sneige N; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2016 Jul; Vol. 158 (1), pp. 67-77. Date of Electronic Publication: 2016 Jun 10.
Autor:
Patel SP; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Schwaederle M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Daniels GA; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Fanta PT; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Schwab RB; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Shimabukuro KA; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Kesari S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Piccioni DE; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Bazhenova LA; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Helsten TL; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Lippman SM; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Parker BA; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2015 Oct 20; Vol. 6 (32), pp. 32602-9.
Autor:
Kim JS; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Present address: Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Kim ES; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Behrens C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lippman SM; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hong WK; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee E; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Publikováno v:
Oncotarget [Oncotarget] 2015 Jun 30; Vol. 6 (18), pp. 16746-56.
Autor:
Wen CP; Institute of Population Health Science, National Health Research Institutes, Zhunan, Taiwan. China Medical University Hospital, Taichung, Taiwan., Zhang F; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liang D; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas., Wen C; Department of Radiological Sciences, University of California at Irvine, Irvine, California., Gu J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Skinner H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chow WH; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ye Y; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pu X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hildebrandt MA; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huang M; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chen CH; Digestive Disease Center, Show-Chwan Memorial Hospital, Changhua, Taiwan., Hsiung CA; Institute of Population Health Science, National Health Research Institutes, Zhunan, Taiwan., Tsai MK; Institute of Population Health Science, National Health Research Institutes, Zhunan, Taiwan., Tsao CK; MJ Health Management Institution, Taipei, Taiwan., Lippman SM; UC San Diego Moores Cancer Center, San Diego, California., Wu X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. xwu@mdanderson.org.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Jan 01; Vol. 21 (1), pp. 193-200. Date of Electronic Publication: 2014 Oct 21.
Autor:
Blumenschein GR Jr; Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Biostatistics and Applied Mathematics, Translational Molecular Pathology, Diagnostic Imaging, Diagnostic Radiology, and Bioinformatics and Computational Biology; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; The Hamon Center for Therapeutic Oncology Research and Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Charlotte, North Carolina; Medical Oncology, Yale Cancer Center, New Haven, Connecticut; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario; Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland; UC San Diego Moores Cancer Center, La Jolla, California; and Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France., Saintigny P, Liu S, Kim ES, Tsao AS, Herbst RS, Alden C, Lee JJ, Tang X, Stewart DJ, Kies MS, Fossella FV, Tran HT, Mao L, Hicks ME, Erasmus J Jr, Gupta S, Girard L, Peyton M, Diao L, Wang J, Davis SE, Minna JD, Wistuba I, Hong WK, Heymach JV, Lippman SM
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Dec 15; Vol. 19 (24), pp. 6967-75. Date of Electronic Publication: 2013 Oct 28.
Autor:
Wang Y; Departments of Epidemiology and Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X
Publikováno v:
Cancer research [Cancer Res] 2013 Aug 01; Vol. 73 (15), pp. 4801-9. Date of Electronic Publication: 2013 Jun 17.
Autor:
Tam AL; Department of Diagnostic Radiology, Unit 1471, The University of Texas, M.D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230, USA. alda.tam@mdanderson.org, Kim ES, Lee JJ, Ensor JE, Hicks ME, Tang X, Blumenschein GR, Alden CM, Erasmus JJ, Tsao A, Lippman SM, Hong WK, Wistuba II, Gupta S
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2013 Apr; Vol. 8 (4), pp. 436-42.